Clinical Trial Update: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of diclofenac sodium topical gel 1% applied four times daily in subjects with acute blunt trauma injuries; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blunt Soft Tissue Injuries Contusions

Drugs mentioned

• Voltaren Gel (diclofenac sodium topical gel 1%) (diclofenac sodium topical gel 1%)

Snippet

Sponsor: Novartis | Conditions: Acute Blunt Soft Tissue Injuries/Contusions | Phase 3 | Status: COMPLETED | Results posted: 2013-01-10